These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30057380)

  • 1. High‑density lipoprotein cholesterol levels and pulmonary artery vasoreactivity in patients with idiopathic pulmonary arterial hypertension.
    Jonas K; Magoń W; Waligóra M; Seweryn M; Podolec P; Kopeć G
    Pol Arch Intern Med; 2018 Aug; 128(7-8):440-446. PubMed ID: 30057380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiac catheterization and pulmonary vasoreactivity testing in children with idiopathic pulmonary arterial hypertension].
    Zhang C; Li Q; Liu T; Gu H
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):468-72. PubMed ID: 25190170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blockers in patients with pulmonary arterial hypertension receiving PAH-specific treatment.
    Hirakawa K; Asano R; Ueda J; Aoki T; Tsuji A; Ogo T
    Int J Cardiol; 2024 Jul; 406():132043. PubMed ID: 38614366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Vascular Capacitance is Associated with Vasoreactivity and Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension.
    Cheng XL; He JG; Liu ZH; Gu Q; Ni XH; Zhao ZH; Luo Q; Xiong CM
    Lung; 2016 Aug; 194(4):613-8. PubMed ID: 27272652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.
    Sitbon O; Humbert M; Jaïs X; Ioos V; Hamid AM; Provencher S; Garcia G; Parent F; Hervé P; Simonneau G
    Circulation; 2005 Jun; 111(23):3105-11. PubMed ID: 15939821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era.
    Gerhardt F; Fiessler E; Olsson KM; Kayser MZ; Kovacs G; Gall H; Ghofrani HA; Badr Eslam R; Lang IM; Benjamin N; Grünig E; Halank M; Lange TJ; Ulrich S; Leuchte H; Held M; Klose H; Ewert R; Wilkens H; Pizarro C; Skowasch D; Wissmüller M; Hellmich M; Olschewski H; Hoeper MM; Rosenkranz S
    Circulation; 2024 May; 149(20):1549-1564. PubMed ID: 38606558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Vascular Capacitance as a Predictor of Vasoreactivity in Idiopathic Pulmonary Arterial Hypertension Tested by Adenosine.
    Shafie D; Dohaei A; Amin A; Taghavi S; Naderi N
    Res Cardiovasc Med; 2015 Nov; 4(4):e28945. PubMed ID: 26528452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and survival of Korean idiopathic pulmonary arterial hypertension patients based on vasoreactivity.
    Ahn JH; Kang BJ; Hong SI; Lee JS; Lee JS; Oh YM; Lee SD
    J Korean Med Sci; 2014 Dec; 29(12):1665-71. PubMed ID: 25469067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effect of iloprost inhalation and oral sildenafil during acute vasoreactivity test in pulmonary arterial hypertension.
    Sompradeekul S; Wattanasiriphakdee S
    J Med Assoc Thai; 2015 Feb; 98(2):144-9. PubMed ID: 25842794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of acute vasodilator response in pulmonary arterial hypertension: beyond the "classic" responders.
    Halliday SJ; Hemnes AR; Robbins IM; Pugh ME; Zhao DX; Piana RN; Fong PP; Brittain EL
    J Heart Lung Transplant; 2015 Mar; 34(3):312-8. PubMed ID: 25577565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual pulmonary vasodilative reserve predicts outcome in idiopathic pulmonary hypertension.
    Leuchte HH; Baezner C; Baumgartner RA; Muehling O; Neurohr C; Behr J
    Heart; 2015 Jun; 101(12):972-6. PubMed ID: 26015441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of calcium channel blockers evaluated by cardiopulmonary exercise testing in idiopathic pulmonary arterial hypertension responding to acute pulmonary vasoreactivity testing.
    Tang Y; Yao L; Liu Z; Ma X; Luo Q; Zhao Z; Huang Z; Tu L; Gao L; Jin Q; Ni X; Xiong C
    Pulm Pharmacol Ther; 2017 Apr; 43():26-31. PubMed ID: 28159512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute vasoreactivity testing with nicardipine in patients with pulmonary arterial hypertension.
    Saito Y; Nakamura K; Miyaji K; Akagi S; Mizoguchi H; Ogawa A; Fuke S; Fujio H; Kiyooka T; Nagase S; Kohno K; Morita H; Kusano KF; Matsubara H; Ohe T; Ito H
    J Pharmacol Sci; 2012; 120(3):206-12. PubMed ID: 23117888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic profile of severity at pulmonary vasoreactivity test in schistosomiasis patients.
    Japyassú FA; Mendes AA; Bandeira ÂP; Oliveira FR; Sobral Filho D
    Arq Bras Cardiol; 2012 Sep; 99(3):789-96. PubMed ID: 22836358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic thromboembolic and pulmonary arterial hypertension share acute vasoreactivity properties.
    Ulrich S; Fischler M; Speich R; Popov V; Maggiorini M
    Chest; 2006 Sep; 130(3):841-6. PubMed ID: 16963684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease.
    Latus H; Wagner I; Ostermayer S; Kerst G; Kreuder J; Schranz D; Apitz C
    Pediatr Cardiol; 2017 Oct; 38(7):1342-1349. PubMed ID: 28681131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of factors related to pulmonary hypertensive crisis in patients with idiopathic pulmonary arterial hypertension].
    Zhang C; Li Q; Zhu Y; Gu H
    Zhonghua Yi Xue Za Zhi; 2014 Jun; 94(22):1687-91. PubMed ID: 25151895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics of 161 Chinese patients with idiopathic pulmonary arterial hypertension].
    Jia WB; Jiang X; Zuo XR; He J; Zhao QH; Jiang R; Jing ZC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Aug; 40(8):652-6. PubMed ID: 23141008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-arginine plasma levels and severity of idiopathic pulmonary arterial hypertension.
    Beyer J; Kolditz M; Ewert R; Rubens C; Opitz C; Schellong S; Hoeffken G; Halank M
    Vasa; 2008 Feb; 37(1):61-7. PubMed ID: 18512543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost.
    Wolff B; Lodziewski S; Bollmann T; Opitz CF; Ewert R
    Am Heart J; 2007 Jun; 153(6):1088.e1-7. PubMed ID: 17540215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.